Join the club for FREE to access the whole archive and other member benefits.

Jim Mellon plans to take his longevity company Juvenescence public

The company with $170 million private funding has invested in various life extension therapies

29-Sep-2020

Key points from article :

Billionaire Jim Mellon to take his life extension company Juvenescence public in the next 6 to 12 months.

Juvenescence is investing in a wide range of anti-ageing therapies.

The company has identified the investment banks it wants to work with.

But the IPO (initial public offering) appears to be running behind schedule.

Juvenescence has raised about $170 million privately & still has a fair amount of money in the bank.

Several other billionaires have invested in the company. 

“I would think that there’s a good chance that I’m going to live to 100 plus.” - Jim Mellon, British Billionaire.

Mentioned in this article:

Click on resource name for more details.

Jim Mellon

British entrepreneur, author and philanthropist with interests across a number of industries

Juvenescence

Developing therapies against different aging related diseases.

Topics mentioned on this page:
Investments